Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
NPCE
#2910
Neuropace, Inc. Common Stock
15.490
0
USD
+0.91%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
+0.91%
Mudança mensal
+8.32%
Mudança em 6 meses
+46.41%
Mudança anual
+46.41%
Fechamento anterior
15.350
0
Abrir
15.430
0
Bid
Ask
Mínimo
15.430
0
High
15.490
0
Volume
6
Mercados
Ações
Cuidados de saúde
NPCE
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
32.56 M
32.8 M
33.08 M
33.31 M
33.67 M
—
Valuation ratios
Enterprise value
410.44 M
435.86 M
404.29 M
381.5 M
557.01 M
1.78 B
Price to earnings ratio
-12.03
-14.99
-13.59
-13.93
-23.39
-65.9
Price to sales ratio
4.08
4.33
3.86
3.44
5.05
16.7
Price to cash flow ratio
-18.16
-20.62
-21.24
-19.66
-45.91
-107.42
Price to book ratio
40.67
7.14
5.65
4.69
26.55
44.03
Enterprise value to EBITDA ratio
-19.98
-23.82
-21.44
-22.14
-35.87
-103.27
Profitability ratios
Return on assets %
-0.06
-0.06
-0.08
-0.03
-0.03
-0.2
Return on equity %
-0.66
-0.27
-0.45
-0.19
-0.14
-1.05
Return on invested capital %
—
-67.6
-88.98
-34.72
-23.86
-215.16
Gross margin %
75.41
76.99
77.09
77.39
77.4
308.87
Operating margin %
-17.02
-22.85
-29.01
-9.51
-6.65
-68.02
EBITDA margin %
-16.97
-22.42
-28.35
-8.88
-6.45
-66.1
Net margin %
-24.46
-29.25
-36.78
-12.78
-10.26
-89.08
Liquidity ratios
Quick ratio
4.48
5.7
4.51
3.94
4.33
18.49
Current ratio
5.37
6.63
5.47
4.86
5.28
22.24
Inventory turnover
0.41
0.38
0.36
0.36
0.34
1.45
Asset turnover
0.22
0.22
0.22
0.26
0.25
0.94
Solvency ratios
Debt to assets ratio
0.63
0.54
0.55
0.55
0.56
2.2
Debt to equity ratio
7.43
2.46
3.02
3.17
3.09
11.75
Long term debt to total assets ratio
0.63
0.54
0.55
0.55
0.56
2.2
Long term debt to total equity ratio
7.43
2.46
3.02
3.17
3.09
11.75
Per share metrics
Operating cash flow per share
-0.16
-0.24
-0.06
-0.06
0.02
-0.34
EBIT per share
-0.13
-0.16
-0.21
-0.08
-0.05
-0.5
EBITDA per share
-0.13
-0.16
-0.2
-0.07
-0.05
-0.49
Total debt per share
2.04
1.9
1.78
1.77
1.8
7.26
Cash per share
1.81
2.11
1.89
1.81
1.87
7.67
Net current asset value per share
2.79
3.1
2.85
2.88
2.87
11.7
Tangible book value per share
0.28
0.77
0.59
0.56
0.58
2.5
Working capital per share
2.27
2.63
2.33
2.29
2.33
9.58
Book value per share
0.28
0.77
0.59
0.56
0.58
2.5
Notícias
Key Catalysts That Will Likely Drive Prospects for NPCE Stock in 2026
NPCE RNS System Explained: Growth Drivers and Setup for 2026
NeuroPace's Seizure ID and New Indication Could Expand RNS Demand
Diretora médica da Neuropace (NPCE) vende US$ 399 mil em ações
Neuropace (NPCE) chief medical officer sells $399k in stock
NeuroPace, Inc. (NPCE) Q4 2025 Earnings Call Transcript
NeuroPace, Inc. (NPCE) Reports Q4 Loss, Beats Revenue Estimates
NeuroPace supera estimativas com receita do 4º trimestre em alta de 24%
NeuroPace beats estimates as Q4 revenue surges 24%, sending shares up 15%
Lucro da Neuropace superou projeções por $0,10; receita supera estimativas
Neuropace earnings beat by $0.10, revenue topped estimates
LivaNova (LIVN) Tops Q4 Earnings and Revenue Estimates